1 study on Pgc 1α mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research identifies Semax as a potent pharmacological activator of the `PGC-1α` pathway in the context of ischemic brain injury. For individuals exploring neuroprotective agents, this provides a specific mechanis…